BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28631176)

  • 21. ETV6-related thrombocytopenia and leukemia predisposition.
    Di Paola J; Porter CC
    Blood; 2019 Aug; 134(8):663-667. PubMed ID: 31248877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
    Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
    Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
    Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between GATA2 and DDX41-mutated myeloid neoplasms.
    Nanaa A; He R; Viswanatha D; Nguyen P; Jevremovic D; Foran JM; Yi CA; Greipp PT; Gangat N; Patnaik M; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Badar T; Alkhateeb HB; Al-Kali A
    Leuk Res; 2022 Oct; 121():106931. PubMed ID: 36037623
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
    Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
    Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
    Lamolda M; Montes R; Simón I; Perales S; Martínez-Navajas G; Lopez-Onieva L; Ríos-Pelegrina R; Del Moral RG; Griñan-Lison C; Marchal JA; Lozano ML; Ramos-Mejia V; Rivera J; Bastida JM; Real PJ
    Stem Cell Res; 2019 Dec; 41():101603. PubMed ID: 31698193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited DDX41 mutations: 11 genes and counting.
    Tawana K; Fitzgibbon J
    Blood; 2016 Feb; 127(8):960-1. PubMed ID: 26917736
    [No Abstract]   [Full Text] [Related]  

  • 28. ETV6 mutations and loss in AML-M0.
    Silva FP; Morolli B; Storlazzi CT; Zagaria A; Impera L; Klein B; Vrieling H; Kluin-Nelemans HC; Giphart-Gassler M
    Leukemia; 2008 Aug; 22(8):1639-43. PubMed ID: 18305557
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
    Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
    Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia.
    Ogawa S; Yokoyama Y; Suzukawa K; Nanmoku T; Kurita N; Seki M; Maie K; Suyama T; Takaiwa N; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Ann Hematol; 2015 Aug; 94(8):1431-3. PubMed ID: 25933678
    [No Abstract]   [Full Text] [Related]  

  • 31. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.
    Berger G; van den Berg E; Sikkema-Raddatz B; Abbott KM; Sinke RJ; Bungener LB; Mulder AB; Vellenga E
    Leukemia; 2017 Feb; 31(2):520-522. PubMed ID: 27795557
    [No Abstract]   [Full Text] [Related]  

  • 32. Germ line predisposition to myeloid malignancies appearing in adulthood.
    Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
    Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
    Connelly JP; Kwon EM; Gao Y; Trivedi NS; Elkahloun AG; Horwitz MS; Cheng L; Liu PP
    Blood; 2014 Sep; 124(12):1926-30. PubMed ID: 25114263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia.
    Duployez N; Abou Chahla W; Lejeune S; Marceau-Renaut A; Letizia G; Boyer T; Geffroy S; Peyrouze P; Grardel N; Nelken B; Michel G; Bertrand Y; Preudhomme C
    Eur J Haematol; 2018 Jan; 100(1):104-107. PubMed ID: 29034503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
    Fox LC; Tan M; Brown AL; Arts P; Thompson E; Ryland GL; Lickiss J; Scott HS; Poplawski NK; Phillips K; Came NA; James P; Ting SB; Ritchie DS; Szer J; Hahn CN; Schwarer A; Blombery P
    Br J Haematol; 2020 Sep; 190(5):e297-e301. PubMed ID: 32488879
    [No Abstract]   [Full Text] [Related]  

  • 36. A Rare Case of ETV6/MECOM Rearrangement in Therapy-Related Acute Myeloid Leukemia with t(3;12) and Monosomy 7.
    Kim YJ; Yang JJ; Han Y; Kim S; Yang HS; Yoon HJ; Lee JH; Lee WI; Park TS
    Clin Lab; 2017 Feb; 63(2):415-418. PubMed ID: 28182364
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia.
    Haslam K; Langabeer SE; Hayat A; Conneally E; Vandenberghe E
    Br J Haematol; 2016 Oct; 175(1):161-3. PubMed ID: 26525156
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.
    Sowa AS; Meloni-Ehrig AM; Tos A; Jahn J; Dogra S; Nava VE; Kelly JC; Mowrey PN
    Cancer Genet Cytogenet; 2010 Dec; 203(2):352-4. PubMed ID: 21156259
    [No Abstract]   [Full Text] [Related]  

  • 39. Biallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemia.
    Yamamoto K; Yakushijin K; Funakoshi Y; Inui Y; Okamura A; Matsuoka H; Minami H
    Leuk Res; 2011 Nov; 35(11):e212-4. PubMed ID: 21803420
    [No Abstract]   [Full Text] [Related]  

  • 40. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
    Owen C
    Leuk Res; 2010 Feb; 34(2):141-2. PubMed ID: 19695705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.